Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2017
At a glance
- Drugs TAC 302 (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 07 Aug 2017 Status changed from not yet recruiting to recruiting.
- 08 Jun 2017 New trial record